TSX News -
The Manganese Battery Hill Project in New Brunswick, Canada Celebrates Elon Musk Tesla Battery Day
Toronto, Canada , Sept. 21, 2020 (GLOBE NEWSWIRE) — Manganese X Energy Corp. (TSXV: MN)(FSE: 9SC2)(OTC: MNXXF), A Canadian company’s […]
TLC to Present at Oppenheimer Fall Healthcare Life Sciences & Med Tech Summit
SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Sept. 21, 2020 (GLOBE NEWSWIRE) — TLC (Nasdaq: TLC, TWO: 4152), a clinical-stage […]
Anglian Water Launches its Digital Transformation with Bottomline
LONDON, Sept. 21, 2020 (GLOBE NEWSWIRE) — Bottomline (NASDAQ:EPAY), a leading provider of financial technology that makes business payments simple, […]
Compass Lexecon Opens Copenhagen Office and Affiliates with Former Danish Competition Authority Chief Economist
COPENHAGEN, Denmark, Sept. 21, 2020 (GLOBE NEWSWIRE) — Compass Lexecon, a subsidiary of FTI Consulting, Inc. (NYSE: FCN), today announced […]
Far Resources Ltd is Pleased to Report the Commencement of its October 2020 Exploration of the Winston Little Granite Epithermal Vein System Lead by Lindsay Bottomer P.Geo & Micheal N. Feinstein PhD
VANCOUVER, British Columbia, Sept. 21, 2020 (GLOBE NEWSWIRE) — FAR Resources Ltd (CSE: FAT) is pleased to announce it has […]
Major Precious Metals Completes Skaergaard Site Visit
VANCOUVER, British Columbia, Sept. 21, 2020 (GLOBE NEWSWIRE) — Major Precious Metals Corp. (“Major Precious Metals” or the “Company”) (CSE:SIZE […]
Intended Delisting and Cancellation of Ordinary Shares from Trading on AIM
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) NO. 596/2014 (“MAR”). […]
Victory Square Health Provides a Progress Update on its Covid-19 Test
VANCOUVER, British Columbia, Sept. 20, 2020 (GLOBE NEWSWIRE) — Victory Square Health Inc. (“VS Health” or the “Company“) – a […]
iCAD Responds to CMS’ Finalized Radiation Oncology Alternative Payment Model
NASHUA, N.H., Sept. 20, 2020 (GLOBE NEWSWIRE) — iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer […]
MacroGenics Announces Presentation of MGD019 Phase 1 Data at the ESMO Virtual Congress 2020
MGD019 well-tolerated with early signals of activity in advanced solid tumors not typically responsive to checkpoint inhibitionRecommended Phase 2 dose […]
